Secondly, we assessed the activity of 2227 signaling pathways (including KEGG: 186; Biocarta: 292; Reactome: 1553; and Pid: 196) across individual tumor cells in our scRNA-seq data and tumor samples in the SU2C cohort (Supplementary information, Table S2). This evidence concerns the gene MTA2 and neoplasm.